Jaguar Health Announces New Japan Patent
Portfolio Pulse from Bill Haddad
Jaguar Health has announced that it has been granted a new patent in Japan. The patent is for the company's proprietary drug, Mytesi, which is used for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
September 13, 2023 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jaguar Health's new patent in Japan for its proprietary drug, Mytesi, could potentially open up a new market for the company, potentially leading to increased revenues.
The new patent in Japan for Jaguar Health's proprietary drug, Mytesi, could potentially open up a new market for the company. This could lead to increased revenues in the future, which would likely have a positive impact on the company's stock price. However, the actual impact will depend on the success of the drug in the Japanese market.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100